Tislelizumab+Oxaliplatin+Capecitabine

BIOLOGICAL2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., RemeGen Co., Ltd.

Conditions

Advanced Solid TumorGastric Carcinoma

Phase 1

Clinical Studies for the Treatment of Advanced Solid Tumors

RecruitingNCT06825494

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Advanced Solid Tumor

Start: 2025-04-08End: 2026-09-30Target: 194Updated: 2025-12-18

Phase 3

A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Not yet recruitingNCT06944496

RemeGen Co., Ltd.Gastric Carcinoma

Start: 2025-05-15End: 2030-05-15Target: 616Updated: 2025-04-25